483 Kashiv BioSciences Jan 2022

483 Kashiv BioSciences Jan 2022

Maria Gutierrez-Hoffman FDA, Riley Myers FDA, Wendy Tan FDA, Nibin Varghese FDA, Rong Wang FDA$119.00 - Available Now

FDA investigators audited the Kashiv BioSciences - Chicago, IL, United States facility and issued inspectional observations (via FDA 483) on 14 Jan 2022.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Jan 2022
  • Location: Chicago, United States
  • FEI: 3011289655
Add To Cart